The Global Thrombectomy Devices Market Continues To Grow Owing To the Increased Rate of Cardiovascular Diseases Such As Strokes All Over the Globe and New Product Launches

 

Thrombectomy devices are used in treating thrombectomy, which is a medical procedure that involves the reconstruction of blood vessels and the removal of a part of the diseased portion of the thrombosed vein or the vein which is infected. The procedure of thrombectomy has gained popularity all over the world in recent times because it provides a very effective cure for various thrombosis-related conditions. As technology advances, thrombectomy devices are also coming up in the market. Though these devices are used for the external application they also have a great scope of application within the internal areas of the human body. A thrombectomy device is a specialized surgical instrument that is used to remove the infected part from one part of the body (the region where there is a thrombosed vein) by the process of coagulation.

The procedure of coagulation involves fusing red blood cells with clotting agents which causes contraction of the blood vessels. Once the coagulation has been completed then the doctors can easily remove the infected part. There are many types of thrombectomy instruments available for this procedure and they include several catheters and laser endoscopy stent. All these instruments are very effective and help in the speedy recovery of patients who have undergone this procedure.

Market Dynamics                                               

The main factor influencing the market growth of thrombectomy devices is the increasing incidence of cardiac arrest across the globe. For instance, according to the National Institute for Health and Care Excellence (NICE) in 2018, the risk of having a cardiac arrest increases with age, and men and Asian people are more vulnerable to it. Thrombectomy treatment options act as an alternative when there is no access to standard care options such as thrombolysis. Moreover, increasing demand for surgical procedures that involve minimal invasion along with increasing cases related to deep vein thrombosis (DVT), stroke, and pulmonary embolism (PE) are estimated to propel the market growth of thrombectomy devices. For instance, according to the World Health Organization (WHO) in 20o18, cardiac arrest was the second most common illness leading to death in the world accounting for 6.7 million deaths.

However, the high cost associated with the thrombectomy devices is the main restraining factor hindering the growth of the market.

This market is distributed in five regions that include North America, Asia-Pacific, Europe, Africa, and the Middle East, and Latin America. Among these, Europe is estimated to hold a significant share of the thrombectomy devices market owing to the sharp incidence rate of stroke cases along with the increase in the geriatric population in the region. For instance, according to the United Nations, in 2019, in Italy 22.8% of the total population were elderly, aged 65 years and above. The thrombectomy devices market in North America is estimated to witness significant growth owing to the presence of key players and the increase of cardiovascular diseases in the region.

Competitive Analysis

Key players operating in the global thrombectomy devices market include Teleflex Incorporated, Terumo Corporation, Stryker Corporation, Straub Medical AG, Spectranetics Corporation, Stentys SA, Phenox GmbH, Penumbra, Inc., Natec Medical Ltd., Nexgen Medical Systems, Inc., Minnetronix, Inc., Merit Medical Systems, Inc., Medtronic PLC, Johnson & Johnson, Edwards Lifesciences Corporation, Control Medical Technology, Claret Medical, Capture Vascular, BTG International, Boston Scientific Corporation, Argon Medical Devices, Inc., and Applied Medical.

In February 2021, Forest Devices, Inc. (FDI) introduced the positive publication of AlphaStroke technology.